Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 (Prevention)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04530396
What this trial is testing

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19

Who this might be right for
Covid19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 33,758
Not applicableStudy completedNCT05118373
What this trial is testing

Generic Behavioural Change Campaign for COVID-19 Prevention

Who this might be right for
Evaluation Study
Centre for Infectious Disease Research in Zambia 2,004
Large-scale testing (Phase 3)Study completedNCT05091307
What this trial is testing

Ad26.COV2.S and Influenza Vaccines in Healthy Adults

Who this might be right for
COVID-19 Prevention
Janssen Vaccines & Prevention B.V. 861
Large-scale testing (Phase 3)WithdrawnNCT04452643
What this trial is testing

Efficacy of BACMUNE (MV130) in the Prevention of Disease Due to COVID-19 Infection in Healthcare Personnel

Who this might be right for
Covid19
Inmunotek S.L.
Early research (Phase 1)Ended earlyNCT05135650
What this trial is testing

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT05375760
What this trial is testing

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
AstraZeneca 251
Large-scale testing (Phase 3)Study completedNCT04516746
What this trial is testing

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Who this might be right for
COVID-19SARS-CoV-2
AstraZeneca 32,450
Not applicableUnknownNCT04947046
What this trial is testing

Carotid Stenosis Management During COVID-19 Era - Pilot Study

Who this might be right for
Carotid StenosisCarotid Artery DiseasesCarotid Atherosclerosis+2 more
Zealand University Hospital 120
Post-approval studies (Phase 4)Study completedNCT05043324
What this trial is testing

Prevention and Treatment of Patient Before, During, and After Covid-19 Infection

Who this might be right for
Covid19
Nguyen Thi Trieu, MD 82
Testing effectiveness (Phase 2)Ended earlyNCT04377659
What this trial is testing

Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection

Who this might be right for
COVID-19
Memorial Sloan Kettering Cancer Center 9
Post-approval studies (Phase 4)WithdrawnNCT04520620
What this trial is testing

Concentration-effect Relationship of Enoxaparin for Thromboembolic Prevention

Who this might be right for
Sars-CoV2
Centre Hospitalier Universitaire de Saint Etienne
Not applicableStudy completedNCT05315323
What this trial is testing

Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries

Who this might be right for
COVID-19
AstraZeneca 550
Large-scale testing (Phase 3)Study completedNCT05815498
What this trial is testing

MRNA-1283 Injection Compared With mRNA-1273 Injection in Participants ≥12 Years of Age to Prevent COVID-19

Who this might be right for
COVID-19
ModernaTX, Inc. 13,553
Not applicableStudy completedNCT04522128
What this trial is testing

Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?

Who this might be right for
COVIDQuality of LifeBehavior+1 more
University of Manchester 274
Testing effectiveness (Phase 2)Looking for participantsNCT06810934
What this trial is testing

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

Who this might be right for
COVID-19SARS-CoV-2 Infection
Kara Chew 80
Testing effectiveness (Phase 2)Study completedNCT04478071
What this trial is testing

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirus Infection
The University of Texas Health Science Center, Houston 448
Testing effectiveness (Phase 2)Study completedNCT04530136
What this trial is testing

Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Confirmed Coronavirus Disease
Pharming Technologies B.V. 38
Early research (Phase 1)Study completedNCT05844202
What this trial is testing

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Who this might be right for
Sars-CoV-2 Infection
Alvea Holdings, LLC 130
Large-scale testing (Phase 3)UnknownNCT04954092
What this trial is testing

Study of Gam-COVID-Vac in Adolescents

Who this might be right for
Covid19Vaccine Preventable Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 3,000
Early research (Phase 1)Study completedNCT05180500
What this trial is testing

Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis

Who this might be right for
COVID-19PharmacokineticsSafety
Sharon Hillier 50
Next Page